Dr. Jeffrey M. Apple, MD

Dr. Apple practices at Veinsolutions in Austin, Texas.

Dr. Apple's NPI, 1750354924, was assigned on February 8, 2006. Dr. Apple graduated from Joe R. & Teresa Lozano Long School of Medicine in 1997. Dr. Apple holds Texas license K9991.

Dr. Apple's primary practice is Veinsolutions, at 1010 W 40th St, Austin, TX 78756-4010. The practice phone is (512) 459-8753.

Dr. Apple's primary practice is Veinsolutions in Austin, Texas. Dr. Apple is also affiliated with St. David's Medical Center. The medical group on file is Ascension St. John. Dmand AI also links Dr. Apple to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Apple practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Apple's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Apple is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Apple's licenses on file in 4 states: Texas, California, Oklahoma and Tennessee.

Dmand AI lists aortic atherosclerois, arterial blot clot /embolism, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, deep vein thrombosis (DVT), heart device and aorta surgery and leg revascularization among the conditions Dr. Apple treats.

CMS data shows 1,226 Medicare services from Dr. Apple across 26 procedure codes in 2024, for 572 Medicare patients. Medicare paid $179,571 for them.

CMS counts 572 Medicare patients who saw Dr. Apple in 2024. The largest group is 65 to 74, with 247 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Apple's median patient age at 71, with 49% women.

In 2024, Dr. Apple wrote 391 Medicare Part D claims for 174 patients. 57% of them were for generic drugs. CMS names the drug for 304 of them, across 4 drugs with 11 or more claims each, at $116,929 in total drug cost. In 2023, CMS named 273 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Apple for performance year 2024, reported individually. Dr. Apple accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Apple as offering telehealth. CMS counts 27 procedures of leg revascularization (restoring blood flow) by Dr. Apple, more than 87% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Apple, published from 2019 to 2025. 2019 was the busiest year, with 3. The most frequent topics are Stents, Stroke and Carotid Artery Diseases. Dr. Apple has published most often in J Vasc Surg. Dr. Apple's most frequent co-authors are Mazin Issa Foteh, MD, Jeffrey Jim, MD and Norman H. Kumins, MD.

Dmand AI links Dr. Apple to 1 clinical trial. Conditions studied include May-Thurner Syndrome and Vascular Malformations. Open Payments lists research payments to Dr. Apple that name 1 trial.

CMS Open Payments shows 315 general payments to Dr. Apple from 38 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 48% of the total. Cook Medical LLC paid the most, $30,730. It also lists 2 research payments totaling $6,755 from 2016 to 2020, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Apple, most recently ACS Fellow in 2013.

Dr. Apple graduated from Joe R. & Teresa Lozano Long School of Medicine in 1997. Dr. Apple is a member of ACS and SVS.

Dr. Apple is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.